| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
25,578 |
23,722 |
$1.77M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,845 |
6,648 |
$638K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
12,071 |
11,366 |
$485K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,679 |
1,629 |
$235K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,408 |
9,156 |
$138K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,408 |
1,395 |
$122K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,266 |
1,262 |
$115K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,623 |
2,621 |
$100K |
| 87428 |
|
3,273 |
3,195 |
$96K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,322 |
4,316 |
$77K |
| 87276 |
|
4,022 |
3,835 |
$55K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,044 |
1,003 |
$53K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
740 |
740 |
$46K |
| 87275 |
|
4,017 |
3,830 |
$46K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,146 |
4,022 |
$29K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
184 |
184 |
$17K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
192 |
192 |
$17K |
| 86756 |
|
809 |
775 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
324 |
321 |
$9K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
84 |
84 |
$8K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
512 |
489 |
$6K |
| 87807 |
|
475 |
462 |
$5K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
255 |
255 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
96 |
95 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
312 |
312 |
$3K |
| 96127 |
|
637 |
637 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$2K |
| 99381 |
|
13 |
13 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
108 |
106 |
$761.30 |
| 90686 |
|
792 |
792 |
$719.55 |
| 98966 |
|
44 |
44 |
$553.48 |
| 90674 |
|
201 |
201 |
$430.49 |
| 81025 |
|
38 |
38 |
$291.08 |
| 99406 |
|
22 |
22 |
$256.78 |
| 85027 |
|
14 |
14 |
$80.50 |
| 90656 |
|
60 |
60 |
$60.12 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
12 |
12 |
$26.78 |
| 96160 |
|
1,184 |
1,182 |
$12.37 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
13 |
13 |
$7.12 |
| 90677 |
|
181 |
181 |
$0.02 |
| 90723 |
|
402 |
402 |
$0.00 |
| 90680 |
|
1,015 |
1,015 |
$0.00 |
| 90698 |
|
206 |
206 |
$0.00 |
| 90647 |
|
336 |
336 |
$0.00 |
| 90697 |
|
158 |
158 |
$0.00 |
| 90651 |
|
96 |
96 |
$0.00 |
| 90696 |
|
18 |
18 |
$0.00 |
| 90633 |
|
392 |
392 |
$0.00 |
| 90710 |
|
298 |
298 |
$0.00 |
| 90670 |
|
1,486 |
1,486 |
$0.00 |
| 90648 |
|
110 |
110 |
$0.00 |
| 90734 |
|
126 |
126 |
$0.00 |
| 90715 |
|
74 |
74 |
$0.00 |
| 90649 |
|
29 |
29 |
$0.00 |